Click here to enlarge.
PDB ID:
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR30400
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Fang, Z.; Marshall, C.; Nishikawa, T.; Gossert, A.; Jansen, J.; Jahnke, W.; Ikura, M.. "Inhibition of K-RAS4B by a Unique Mechanism of Action: Stabilizing Membrane-Dependent Occlusion of the Effector-Binding Site" Cell Chem. Biol. 25, 1327-1336 (2018).
PubMed: 30122370
Assembly members:
entity_1, polymer, 200 residues, 23234.295 Da.
entity_2, polymer, 187 residues, 21302.330 Da.
entity_PCW, non-polymer, 787.121 Da.
entity_17F, non-polymer, 788.043 Da.
entity_GNP, non-polymer, 522.196 Da.
entity_MG, non-polymer, 24.305 Da.
entity_EWS, non-polymer, 446.768 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli
Entity Sequences (FASTA):
entity_1: GPLKLLDNWDSVTSTFSKLR
EQLGPVTQEFWDNLEKETEG
LRQEMSKDLEEVKAKVQPYL
DDFQKKWQEEMELYRQKVEP
LRAELQEGARQKLHELQEKL
SPLGEEMRDRARAHVDALRT
HLAPYSDELRQRLAARLEAL
KENGGARLAEYHAKATEHLS
TLSEKAKPALEDLRQGLLPV
LESFKVSFLSALEEYTKKLN
entity_2: GSMTEYKLVVVGAVGVGKSA
LTIQLIQNHFVDEYDPTIED
SYRKQVVIDGETCLLDILDT
AGQEEYSAMRDQYMRTGEGF
LCVFAINNTKSFEDIHHYRE
QIKRVKDSEDVPMVLVGNKC
DLPSRTVDTKQAQDLARSYG
IPFIETSAKTRQGVDDAFYT
LVREIRKHKEKMSKDGKKKK
KKSKTKC
Data type | Count |
13C chemical shifts | 25 |
15N chemical shifts | 83 |
1H chemical shifts | 158 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | entity_1, 1 | 1 |
2 | entity_1, 2 | 1 |
3 | entity_2, 1 | 2 |
4 | entity_3, 1 | 3 |
5 | entity_3, 2 | 3 |
6 | entity_3, 3 | 3 |
7 | entity_3, 4 | 3 |
8 | entity_3, 5 | 3 |
9 | entity_3, 6 | 3 |
10 | entity_3, 7 | 3 |
11 | entity_3, 8 | 3 |
12 | entity_3, 9 | 3 |
13 | entity_3, 10 | 3 |
14 | entity_3, 11 | 3 |
15 | entity_3, 12 | 3 |
16 | entity_3, 13 | 3 |
17 | entity_3, 14 | 3 |
18 | entity_3, 15 | 3 |
19 | entity_3, 16 | 3 |
20 | entity_3, 17 | 3 |
21 | entity_3, 18 | 3 |
22 | entity_3, 19 | 3 |
23 | entity_3, 20 | 3 |
24 | entity_3, 21 | 3 |
25 | entity_3, 22 | 3 |
26 | entity_3, 23 | 3 |
27 | entity_3, 24 | 3 |
28 | entity_3, 25 | 3 |
29 | entity_3, 26 | 3 |
30 | entity_3, 27 | 3 |
31 | entity_3, 28 | 3 |
32 | entity_3, 29 | 3 |
33 | entity_3, 30 | 3 |
34 | entity_3, 31 | 3 |
35 | entity_3, 32 | 3 |
36 | entity_3, 33 | 3 |
37 | entity_3, 34 | 3 |
38 | entity_3, 35 | 3 |
39 | entity_3, 36 | 3 |
40 | entity_3, 37 | 3 |
41 | entity_3, 38 | 3 |
42 | entity_3, 39 | 3 |
43 | entity_3, 40 | 3 |
44 | entity_3, 41 | 3 |
45 | entity_3, 42 | 3 |
46 | entity_3, 43 | 3 |
47 | entity_3, 44 | 3 |
48 | entity_3, 45 | 3 |
49 | entity_3, 46 | 3 |
50 | entity_3, 47 | 3 |
51 | entity_3, 48 | 3 |
52 | entity_3, 49 | 3 |
53 | entity_3, 50 | 3 |
54 | entity_3, 51 | 3 |
55 | entity_3, 52 | 3 |
56 | entity_3, 53 | 3 |
57 | entity_3, 54 | 3 |
58 | entity_3, 55 | 3 |
59 | entity_3, 56 | 3 |
60 | entity_3, 57 | 3 |
61 | entity_3, 58 | 3 |
62 | entity_3, 59 | 3 |
63 | entity_3, 60 | 3 |
64 | entity_3, 61 | 3 |
65 | entity_3, 62 | 3 |
66 | entity_3, 63 | 3 |
67 | entity_3, 64 | 3 |
68 | entity_4, 1 | 4 |
69 | entity_4, 2 | 4 |
70 | entity_4, 3 | 4 |
71 | entity_4, 4 | 4 |
72 | entity_4, 5 | 4 |
73 | entity_4, 6 | 4 |
74 | entity_4, 7 | 4 |
75 | entity_4, 8 | 4 |
76 | entity_4, 9 | 4 |
77 | entity_4, 10 | 4 |
78 | entity_4, 11 | 4 |
79 | entity_4, 12 | 4 |
80 | entity_4, 13 | 4 |
81 | entity_4, 14 | 4 |
82 | entity_4, 15 | 4 |
83 | entity_4, 16 | 4 |
84 | entity_5, 1 | 5 |
85 | entity_6, 1 | 6 |
86 | entity_7, 1 | 7 |
Entity 1, entity_1, 1 200 residues - 23234.295 Da.
1 | GLY | PRO | LEU | LYS | LEU | LEU | ASP | ASN | TRP | ASP | |
2 | SER | VAL | THR | SER | THR | PHE | SER | LYS | LEU | ARG | |
3 | GLU | GLN | LEU | GLY | PRO | VAL | THR | GLN | GLU | PHE | |
4 | TRP | ASP | ASN | LEU | GLU | LYS | GLU | THR | GLU | GLY | |
5 | LEU | ARG | GLN | GLU | MET | SER | LYS | ASP | LEU | GLU | |
6 | GLU | VAL | LYS | ALA | LYS | VAL | GLN | PRO | TYR | LEU | |
7 | ASP | ASP | PHE | GLN | LYS | LYS | TRP | GLN | GLU | GLU | |
8 | MET | GLU | LEU | TYR | ARG | GLN | LYS | VAL | GLU | PRO | |
9 | LEU | ARG | ALA | GLU | LEU | GLN | GLU | GLY | ALA | ARG | |
10 | GLN | LYS | LEU | HIS | GLU | LEU | GLN | GLU | LYS | LEU | |
11 | SER | PRO | LEU | GLY | GLU | GLU | MET | ARG | ASP | ARG | |
12 | ALA | ARG | ALA | HIS | VAL | ASP | ALA | LEU | ARG | THR | |
13 | HIS | LEU | ALA | PRO | TYR | SER | ASP | GLU | LEU | ARG | |
14 | GLN | ARG | LEU | ALA | ALA | ARG | LEU | GLU | ALA | LEU | |
15 | LYS | GLU | ASN | GLY | GLY | ALA | ARG | LEU | ALA | GLU | |
16 | TYR | HIS | ALA | LYS | ALA | THR | GLU | HIS | LEU | SER | |
17 | THR | LEU | SER | GLU | LYS | ALA | LYS | PRO | ALA | LEU | |
18 | GLU | ASP | LEU | ARG | GLN | GLY | LEU | LEU | PRO | VAL | |
19 | LEU | GLU | SER | PHE | LYS | VAL | SER | PHE | LEU | SER | |
20 | ALA | LEU | GLU | GLU | TYR | THR | LYS | LYS | LEU | ASN |
Entity 2, entity_2, 1 187 residues - 21302.330 Da.
1 | GLY | SER | MET | THR | GLU | TYR | LYS | LEU | VAL | VAL | ||||
2 | VAL | GLY | ALA | VAL | GLY | VAL | GLY | LYS | SER | ALA | ||||
3 | LEU | THR | ILE | GLN | LEU | ILE | GLN | ASN | HIS | PHE | ||||
4 | VAL | ASP | GLU | TYR | ASP | PRO | THR | ILE | GLU | ASP | ||||
5 | SER | TYR | ARG | LYS | GLN | VAL | VAL | ILE | ASP | GLY | ||||
6 | GLU | THR | CYS | LEU | LEU | ASP | ILE | LEU | ASP | THR | ||||
7 | ALA | GLY | GLN | GLU | GLU | TYR | SER | ALA | MET | ARG | ||||
8 | ASP | GLN | TYR | MET | ARG | THR | GLY | GLU | GLY | PHE | ||||
9 | LEU | CYS | VAL | PHE | ALA | ILE | ASN | ASN | THR | LYS | ||||
10 | SER | PHE | GLU | ASP | ILE | HIS | HIS | TYR | ARG | GLU | ||||
11 | GLN | ILE | LYS | ARG | VAL | LYS | ASP | SER | GLU | ASP | ||||
12 | VAL | PRO | MET | VAL | LEU | VAL | GLY | ASN | LYS | CYS | ||||
13 | ASP | LEU | PRO | SER | ARG | THR | VAL | ASP | THR | LYS | ||||
14 | GLN | ALA | GLN | ASP | LEU | ALA | ARG | SER | TYR | GLY | ||||
15 | ILE | PRO | PHE | ILE | GLU | THR | SER | ALA | LYS | THR | ||||
16 | ARG | GLN | GLY | VAL | ASP | ASP | ALA | PHE | TYR | THR | ||||
17 | LEU | VAL | ARG | GLU | ILE | ARG | LYS | HIS | LYS | GLU | ||||
18 | LYS | MET | SER | LYS | ASP | GLY | LYS | LYS | LYS | LYS | ||||
19 | LYS | LYS | SER | LYS | THR | LYS | CYS |
Entity 3, entity_3, 1 - C44 H85 N O8 P - 787.121 Da.
1 | PCW |
Entity 4, entity_4, 1 - C42 H78 N O10 P - 788.043 Da.
1 | 17F |
Entity 5, entity_5, 1 - C10 H17 N6 O13 P3 - 522.196 Da.
1 | GNP |
Entity 6, entity_6, 1 - Mg - 24.305 Da.
1 | MG |
Entity 7, entity_7, 1 - C21 H21 Br Cl N3 O - 446.768 Da.
1 | EWS |
sample_1: GTPase KRas isoform b, U-15N, Ile, Leu C-delta-13C, Val C-gamma-13C, 0.2 mM; Membrane Scaffold Protein 0.4 mM; sodium chloride 100 mM; TRIS 20 mM; magnesium chloride 5 mM; TCEP 2 mM; GMPPNP 0.2 mM; DOPC 12 mM; DOPS 3.2 mM; PE-MCC 0.8 mM
sample_2: GTPase KRas isoform b, U-15N, Ile, Leu C-delta-13C, Val C-gamma-13C, 0.2 mM; Membrane Scaffold Protein 0.4 mM; sodium chloride 100 mM; TRIS 20 mM; magnesium chloride 5 mM; TCEP 2 mM; GMPPNP 0.2 mM; DOPC 12 mM; DOPS 3.2 mM; PE-MCC 0.8 mM; Cmpd2 1 mM
sample_3: GTPase KRas isoform b, [U-15N], 0.2 mM; sodium chloride 100 mM; TRIS 20 mM; magnesium chloride 5 mM; TCEP 2 mM; GMPPNP 0.2 mM; Cmpd2 1 mM
sample_conditions_1: ionic strength: 100 mM; pH: 7.4; pressure: 1 atm; temperature: 298 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-13C HMQC, 1H-15N TROSY | sample_1 | isotropic | sample_conditions_1 |
2D 1H-13C HMQC, 1H-15N TROSY | sample_2 | isotropic | sample_conditions_1 |
3D_15N-separated_NOESY | sample_3 | isotropic | sample_conditions_1 |
CNS, Brunger A. T. et.al. - refinement
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks